HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$6.65
Day range
$6.38 - $6.72
Year range
$0.66 - $14.30
Market cap
206.31M USD
Avg Volume
290.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.72M | -1.22% |
Net income | -22.24M | -131.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.32M | 10.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.45M | -58.66% |
Total assets | 26.48M | -54.89% |
Total liabilities | 36.46M | 30.50% |
Total equity | -9.97M | — |
Shares outstanding | 32.08M | — |
Price to book | -20.78 | — |
Return on assets | -74.27% | — |
Return on capital | -120.20% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.24M | -131.30% |
Cash from operations | -6.20M | 13.86% |
Cash from investing | -6.00K | 96.45% |
Cash from financing | 1.94M | — |
Net change in cash | -4.26M | 42.16% |
Free cash flow | -3.01M | 21.77% |
About
Founded
2003
Headquarters
Website
Employees
42